Triclabendazole (Compound)

Synonyms:Triclabendazole, 68786-66-3, Fasinex, Egaten, 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo[d]imidazole, Triclabendazol, Triclabendazolum, 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole, NVP-EGA230, EGA230B, 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole, NSC-759250, CPD000466357, MLS001424101, CHEMBL1086440, DTXSID7043952, 1H-Benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-, CGA89317, 4784C8E03O, NCGC00164610-01, SMR000466357, 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole, 6-[2,3-bis(chloranyl)phenoxy]-5-chloranyl-2-methylsulfanyl-1H-benzimidazole, 5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLSULFANYL)-1H-1,3-BENZODIAZOLE, Triclabendazol [INN-Spanish], Triclabendazolum [INN-Latin], CCRIS 8988, CGA 89317, 5-chloro-6-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole, UNII-4784C8E03O, 6-Chloro-5-(2,3-dichlorophenoxy)-2-methylthio-benzimidazole, Fasinex (TN), Egaten (TN), 1H-BENZIMIDAZOLE, 5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLTHIO)-, TRICLABENDAZOLE [MI], Oprea1_236106, Triclabendazole (USAN/INN), TRICLABENDAZOLE [INN], cid_50248, MLS000759473, MLS000876812, SCHEMBL165712, TRICLABENDAZOLE [USAN], TRICLABENDAZOLE [MART.], DTXCID5023952, TRICLABENDAZOLE [WHO-DD], BDBM58491, CHEBI:94759, Triclabendazole [USAN:INN:BAN], HMS2051E16, HMS2232D14, HMS3370H02, HMS3393E16, HMS3652M16, HMS3715P16, HMS3744I09, KUC103451N, Pharmakon1600-01505786, HY-B0621, Tox21_112231, CGA-89317, MFCD00864519, NSC759250, s4114, STK332284, TRICLABENDAZOLE [ORANGE BOOK], AKOS005439340, AKOS015950804, AC-7627, AT10531, CCG-100881, CCG-268150, DB12245, KS-5329, NC00131, NSC 759250, SB17173, NCGC00164610-02, SBI-0207022.P001, CAS-68786-66-3, FT-0602564, SW197511-2, T2826, Triclabendazole 100 microg/mL in Acetonitrile, D07364, AB00639964-10, AB00639964_12, AB00639964_13, A836250, Q419739, SR-01000759363, SR-01000759363-4, Triclabendazole, VETRANAL(TM), analytical standard, BRD-K81916719-001-05-5, Z3069281092, 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole, Triclabendazole, EuropePharmacopoeia (EP) Reference Standard, 5-Chloro-6-(2',3'-dichlorophenoxy)-2-(methylthio)benzimidazole, 5-chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo[d]imidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-1,3-benzodiazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-benzimidazole, 5-[2,3-bis(chloranyl)phenoxy]-6-chloranyl-2-methylsulfanyl-1H-benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole;Triclabendazole, Triclabendazole for system suitability, EuropePharmacopoeia (EP) Reference Standard, JA9
Pubchem:PUBCHEM:50248
Id:0c3a79c8-b588-5d31-b34d-2f29b3158346
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Triclabendazole's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Triclabendazole.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Triclabendazole.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.